Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | F10 | P00742 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6348623 | 0.88 | ALB (0.62) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL6350787 | 0.84 | PPARG (0.63) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL6710185 | 0.80 | MAPT (0.57) | ALBMAPTTP53MEN1KMT2A | |
| SCHEMBL6351357 | 0.80 | TP53 (0.46) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL6707734 | 0.79 | MAPT (0.61) | ALBMAPTTP53MEN1KMT2A | |
| SCHEMBL6350657 | 0.78 | PPARG (0.59) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL6346501 | 0.78 | PPARG (0.53) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL6835789 | 0.78 | ALB (0.46) | ALBMAPTPPARGPPARDPPARA | |
| SCHEMBL15788196 | 0.76 | MAPT (0.61) | MAPTPPARGPPARDPPARATP53 | |
| SCHEMBL6359100 | 0.76 | MAPT (0.61) | MAPTTP53MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885MAPT 4759/4885PPARG 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.